TGF-β1 siRNA suppresses the tubulointerstitial fibrosis in the kidney of ureteral obstruction

被引:63
作者
Hwang, Meeyul
Kim, Hye-Jin
Noh, Hey-Jeong
Chang, Young-Chae
Chae, Young-Mi
Kim, Kyung-Hyun
Jeon, Jae-Pil
Lee, Tae-Sung
Oh, Hoon-Kyu
Lee, Yun-Sik
Park, Kwan-Kyu [1 ]
机构
[1] Catholic Univ Daegu, Sch Med, Dept Pathol, Taegu, South Korea
[2] Catholic Univ Daegu, Sch Med, Res Inst Med Sci, Taegu, South Korea
[3] Natl Genome Res Inst, Div Genome Resources, NIH, Seoul, South Korea
[4] Univ Penn, Sch Med, Dept Endocrinol, Philadelphia, PA 19104 USA
关键词
TGF-beta; 1; tubulointerstitial fibrosis; siRNA; unilateral ureteral obstruction (UUO); gene therapy;
D O I
10.1016/j.yexmp.2005.11.005
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
TGF-beta 1 has been known as an important factor in tubulointerstitial fibrosis which is a common process in most progressive renal diseases. We hypothesized that the interstitial fibrosis could be prevented by abolishing TGF-1 function in unilateral ureteral obstruction (UUO)-induced renal fibrosis. shRNA vectors were generated to suppress TGF-beta 1 expression at a high glucose concentration which allowed the maximal induction of TGF-1 in primary rat mesangial cells. An shRNA vector, designated shTB1d, significantly suppressed TGF-beta 1 in both transcriptional and translational levels in vitro cultured cells and in vivo fibrosis-induced mouse kidney, accompanied by the suppression of target genes (e.g., type 1 collagen and PAI-1) of TGF-beta 1. Furthermore, the shTB1d suppressed the expression of TGF-beta 1 and type 1 collagen in tabulointerstitial cells until day 7 after UUO-induced fibrosis, but none- or vector-treated mice maintained their expression, suggesting that the TGF-beta 1 shRNA delays the process of renal fibrosis in UUO mouse model. This work would provide a valuable tool to prevent tubulointerstitial fibrosis using RNA interference strategy. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:48 / 54
页数:7
相关论文
共 32 条
[1]   Inhibition of TGF-beta 1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis [J].
Akagi, Y ;
Isaka, Y ;
Arai, M ;
Kaneko, T ;
Takenaka, M ;
Moriyama, T ;
Kaneda, Y ;
Ando, A ;
Orita, Y ;
Kamada, T ;
Ueda, N ;
Imai, E .
KIDNEY INTERNATIONAL, 1996, 50 (01) :148-155
[2]   Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo [J].
Bertrand, JR ;
Pottier, M ;
Vekris, A ;
Opolon, P ;
Maksimenko, A ;
Malvy, C .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 296 (04) :1000-1004
[3]   TGF-beta in kidney fibrosis: A target for gene therapy [J].
Border, WA ;
Noble, NA .
KIDNEY INTERNATIONAL, 1997, 51 (05) :1388-1396
[4]   Novel antisense and peptide nucleic acid strategies for controlling gene expression [J].
Braasch, DA ;
Corey, DR .
BIOCHEMISTRY, 2002, 41 (14) :4503-4510
[5]   A system for stable expression of short interfering RNAs in mammalian cells [J].
Brummelkamp, TR ;
Bernards, R ;
Agami, R .
SCIENCE, 2002, 296 (5567) :550-553
[6]   MECHANISMS OF PROGRESSIVE RENAL DISEASE IN GLOMERULONEPHRITIS [J].
COUSER, WG ;
JOHNSON, RJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 23 (02) :193-198
[7]   How is type I procoflagen synthesis regulated at the gene level during tissue fibrosis [J].
Cutroneo, KR .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2003, 90 (01) :1-5
[8]  
ELBAKRI IA, 2001, P SOC PHOTO-OPT INS, V2, P1, DOI DOI 10.1117/12.430961)
[9]   Amplification of RNAi - Targeting HLA mRNAs [J].
Gonzalez, S ;
Castanotto, D ;
Li, HT ;
Olivares, S ;
Jensen, MC ;
Forman, SJ ;
Rossi, JJ ;
Cooper, LJN .
MOLECULAR THERAPY, 2005, 11 (05) :811-818
[10]   Treatment of chronic tubulointerstitial disease: A new concept [J].
Hruska, KA .
KIDNEY INTERNATIONAL, 2002, 61 (05) :1911-1922